Supply Chain

As prescription drug prices continue to rise and the popularity of high-deductible health plans grow, patients across the U.S. are shouldering the higher price of their medications.

After combing through 149 proposals for its Unmanned Aircraft Systems Integration Pilot Program — which seeks to operationalize drones in safe and unique ways — the U.S. Department of Transportation, in partnership with the Federal Aviation Administration, selected 10 winners…

Eli Lilly and Co. entered a definitive agreement to purchase the immuno-oncology company Armo BioSciences for about $1.6 billion, the drugmaker announced May 10.

Salix Pharmaceuticals aims to simplify the preparation process for colonoscopies with its new FDA-approved bowel cleanser, Plenvu, the company announced May 7.

Jazz Pharmaceuticals will pay $57 million as part of a tentative deal with the U.S. Department of Labor to settle an investigation into the drugmaker's donations to patient assistance charities, reports Bloomberg.

Takeda Pharmaceutical Co. plans to acquire its much larger rival Shire for $62 billion in cash and stock by Jan. 8 — a deal that would catapult the Japanese company into a new league of drug industry giants, according to a Reuters…

The FDA posted a supply shortage alert for EpiPens and other epinephrine auto-injectors May 9, after patients and pharmacists in 45 states reported it was difficult to find the lifesaving allergic reaction treatment.

Software issues constituted the No. 1 reason for U.S. medical device recalls for the eighth consecutive quarter, according to a recent analysis of 2018 first-quarter recall data.

In a move to distance itself from past controversies involving drug price increases, Valeant Pharmaceuticals will change its name to Bausch Health Cos., according to The Wall Street Journal.

New gene therapies designed to cure hemophilia could cost $1.5 million or more, according to a May 7 Leerink analyst note cited by CNBC.